KRT88P and influenza: Due to viral drifts and shifts, a particular influenza vaccine cannot provide long-term immunity.54 A microbial platform may rapidly provide a vaccine to combat seasonal influenza epidemics.55 The anti-influenza A M2e-HBc vaccine candidate, ACAM-FLU-A, was produced by E. coli.